Workday Shares Rise 5 After Raising Margin Forecast on AI Momentum Micron Technology Hits Record High After Major PriceTarget Upgrade Federal Reserves Path to Rate Cuts Narrowing Amid Persistent Cost of Living Pressures SpaceX Starship Test Flight Scrubbed Retry Set for Friday Amid IPO Prospectus Release Finance Ministry to Meet PSU Bank Heads on Friday to Assess Agricultural and MSME Credit Flow SIP Boom and FPI Exit Examining the Impact on Indian Rupee Stability Diversified Healthcare Trust 5625 Senior Notes due 2042 DHCNI Q1 2026 Earnings Deeper EPS Miss Signals Persistent Headwinds IPST Q1 2026 Earnings Significant EPS Miss Raises Questions RFIL Q1 2026 Earnings Strong EPS Surprise Drives Share Gains Despite Limited Revenue Disclosure Vital Farms Q1 2026 Earnings EPS Misses Estimates as Stock Rises 676 Sanmina Q1 2026 Earnings Strong EPS Surge Defies Estimates ASTI Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue AMC Networks AMCX Surges 367 as Stock Tests Key Resistance Near 1038 Tapestry Inc Holds Steady Near 139 as Traders Eye Key Levels Tredegar Corporation TG Surges 23 Approaches Key Resistance at 84 Clean Harbors CLH Gains 154 as Shares Approach Key Resistance at 30127 Metalla Royalty Streaming MTA Climbs 209 Approaching Key Resistance at 796 China Investors Shift Funds After Crackdown on Overseas Stock Trading HLX Q1 2026 Earnings EPS Misses Estimates as Offshore Services Sector Faces Headwinds Lifeward Ltd LFWD Surges Over 11 as Shares Test Key Resistance IRTC Q1 2026 Earnings Narrowing Losses Beat Expectations as Operating Discipline Drives Results Kadant Inc Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Katapult Holdings Q1 2026 Earnings Massive Profitability Surprise Drives DoubleDigit EPS Beat China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment BCDA Q1 2026 Earnings EPS Misses Estimates as No Revenue Reported Stock Edges Higher Curbline Properties CURB Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds CMMB Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Biotech Continues Without Revenue